Health - Thursday, June 11, 2026

Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug Administration allow…

None of STAT's requests for Kennedy's schedule have been completed, and some haven't even been acknowledged.

A new CDC report underscores that drinking during pregnancy, while generally thought of as a thing of the past, is still a matter of concern.

In this edition of STAT Health Tech: HHS watchdog on denials by health insurers, lawmakers target AI denials, and Talkspace's new chatbot offering.

A potentially dangerous tapeworm linked to severe, cancer-like disease has now been found in the Pacific Northwest, marking its first detection in wild animals along the U.S. West Coast. Researchers discovered the parasite, Echinococcus multilocularis, in 37% of coyotes tested around Puget Sound—a surprisingly high rate for a region where it had never been reported until recently.

In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.

A new study found that the leading environmental factor influencing brain structure and function is the socioeconomic status of a child's family.

Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.

Major Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.

Researchers discovered that declining levels of phosphatidylcholine may be a major cause of age-related mitochondrial dysfunction and loss of cellular energy. Remarkably, boosting this nutrient restored more youthful mitochondrial performance in aging organisms, suggesting some aspects of aging can be slowed or reversed.